Labroots

WEBINAR: The clinical impact and implementation of T2MR and the T2Candida Panel in the management of candidemia at a large tertiary care health system

Learn from renowned clinical expert, George J. Alangaden, M.D., as he discusses how Henry Ford Health System (HFHS) implemented T2MR and the T2Candida Panel as part of their sepsis protocol for the ...
Labroots

The Reason for Resonance: Using T2MR to Advance the Diagnosis of Bloodstream Infections

During the webinar, Dr. Snežana Jovanović will share her experience with T2 Biosystems sepsis diagnostics. Through case studies, participants will examine the role of early diagnosis of bloodstream ...
Yahoo Finance

T2 Biosystems Announces Meta-analysis of Controlled Studies in Peer-Reviewed Medical Journal Highlighting the Benefits of T2MR Technology Compared to Blood Culture

LEXINGTON, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that Expert Review of Medical ...
GEN

Bayer to Use T2 Biosystems’ T2MR Platform in Hemostasis Collaboration

Bayer will use T2 Biosystems’ T2 Magnetic Resonance technology platform (T2MR ®) under a multiyear hemostasis research collaboration whose value was not disclosed. The collaboration, disclosed today ...
Wicked Local

Lexington company's medical innovation has potential to save lives

A new product developed by Lexington-based T2 Biosystems could dramatically improve the survival rate of trauma patients whose bodies are unable to control or stop bleeding. The innovative and ...
EurekAlert!

T2 Bio publishes data supporting diagnostic test T2Candida® in Science Translational Medicine

Lexington, MA, April 24, 2013 (Embargoed until 2:00 PM US Eastern Time) – T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the publication ...
technologynetworks

T2 Biosystems Ink R&D Collaboration with Bayer

T2 Biosystems, Inc. has signed a multi-year agreement to provide T2 Biosystems’ T2 Magnetic Resonance technology platform, or T2MR®, for Bayer’s research and development efforts in blood coagulation ...
Becker's Hospital Review

Sepsis detection: New technology leads to improvements in care and cost savings

When infection strikes, the human body strikes back. Yet that reaction often takes a patient down a more perilous path. The body’s severe inflammatory response can lead to sepsis, a potentially ...
MIT Technology Review

New Sepsis Detector Shrinks the Diagnosis from Days to Hours

Hospitals are beginning to use a new, more potent weapon against sepsis, the devastating condition that kills more than 25 percent of its victims and costs hospitals billions of dollars annually. In ...
Business Wire

T2 Biosystems Submits 510(k) Application to the FDA for Review of T2Dx and T2Candida

LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems today announced that it has filed a 510(k) premarket submission for T2Dx and T2Candida with the U.S. Food and Drug Administration (FDA). The premarket ...
Business Wire

T2 Biosystems Presents New Data at the Thrombosis and Hemostasis Summit of North America Demonstrating Ability of T2MR Platform Technology to Measure Platelet Activity and ...

LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, a company developing direct detection products designed to enable superior diagnostics, today announced the presentation of data highlighting the role ...